Medical Robotics Global Market Report 2024

Medical robots are advanced robotic systems used in healthcare settings to improve patient care. They assist in medical procedures, contribute to the development of healthcare technology, and enhance overall healthcare delivery. Medical robotics technology is utilized in surgeries, radiotherapy treatments, rehabilitation therapies, and other medical applications.

In the field of medical robotics, the main product types are surgical robotics systems, rehabilitation robotics systems, and non-invasive radiosurgery systems. Surgical robotics systems utilize computer technologies and robots to assist in performing medical procedures such as laparoscopy, neurosurgery, cardiology, orthopedic surgery, and pharmacy applications. These systems are commonly used in hospitals, clinics, specialty centers, and rehabilitation centers.

The medical robotics market research report is one of a series of new reports from The Business Research Company that provides medical robotics market statistics, including the medical robotics industry global market size, regional shares, competitors with a medical robotics market share, detailed medical robotics market segments, market trends and opportunities, and any further data you may need to thrive in the medical robotics industry. This medical robotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The medical robotics market size has grown rapidly in recent years. It will grow from $12.76 billion in 2023 to $14.9 billion in 2024 at a compound annual growth rate (CAGR) of 16.8%. The growth during the historical period can be attributed to a rising demand for precision and accuracy in medical procedures, a growing acceptance of minimally invasive surgery, the increase in chronic diseases, investments in research and development, and the expanding range of applications for these technologies in healthcare.

The medical robotics market size is expected to see rapid growth in the next few years. It will grow to $29.22 billion in 2028 at a compound annual growth rate (CAGR) of 18.3%. The projected growth in the forecast period is due to several factors such as the increasing consumer demand for enhanced healthcare services, supportive regulatory frameworks and standards, improved accessibility and affordability in healthcare, the rising demand for remote surgery and telepresence, and the integration of AI and machine learning technologies. Key trends expected during this period encompass the development of patient-centric robotics, advancements in surgical techniques, a surge in minimally invasive surgeries, an expanded role in rehabilitation through robotics, and a growing demand for telepresence and remote surgical procedures.

The increasing preference for minimally invasive surgery (MIS) is playing a significant role in driving the growth of the medical robotics market. Minimally invasive surgery encompasses a range of techniques, including the use of medical robots, to perform surgical procedures with reduced trauma to the body compared to traditional open surgery. This approach is gaining popularity among patients due to its associated benefits, such as reduced postoperative pain, lower risk of complications, shorter hospital stays, and faster recovery times. For example, research conducted by Johns Hopkins investigators and published in JAMA Surgery has shown that American hospitals could prevent thousands of post-surgical complications and save between $280 million and $340 million annually by opting for more minimally invasive procedures for routine operations involving the appendix, colon, and lungs, as compared to traditional open surgery. Additionally, data from the American Society of Plastic Surgeons indicates that in September 2023, there were 26.2 million minimally invasive and surgical treatments performed in the US. As the demand for minimally invasive surgical techniques continues to rise, driven by patient preferences and the associated clinical and economic benefits, the medical robotics market is expected to experience significant growth. This trend underscores the increasing role of medical robotics in enabling and enhancing minimally invasive surgical procedures, thereby driving advancements in healthcare delivery and patient outcomes.

The increasing prevalence of chronic diseases, particularly cardiovascular diseases (CVDs), is expected to drive the growth of the medical robotics market in the coming years. CVDs encompass a group of conditions that affect the circulatory system, including the heart and blood vessels. Medical robots are increasingly used in the treatment of CVDs to perform minimally invasive surgeries, such as robot-assisted cardiac procedures, which can improve surgical precision and reduce patient trauma. For example, data from the Australian Institute of Health and Welfare indicates a concerning rise in doctor-certified fatalities due to coronary heart disease (CHD) in recent years. The number of fatalities increased from 13,700 in 2020 to 14,900 in 2022, based on preliminary mortality figures. This trend underscores the growing impact of chronic diseases such as CVDs on global health and the need for advanced medical technologies such as robotics to address these challenges. Therefore, the increasing prevalence of chronic diseases, particularly cardiovascular diseases, is a significant driver behind the growth of the medical robotics market, as these advanced technologies play a crucial role in improving treatment outcomes and patient care in the face of rising disease burdens.

Strategic collaboration between companies is increasingly becoming a prominent trend in the medical robotics market. Companies operating in this industry are engaging in various collaborations to drive the development of new technologies and products. For example, in February 2022, Novanta, a US-based advanced photonics company, announced a strategic collaboration with MassRobotics, a US-based robotics and AI company, aimed at advancing innovations in medical and surgical robotics. As part of this collaboration, Novanta's business units, Celera Motion and ATI Industrial Automation, will work closely with MassRobotics to develop advanced innovations in medical and surgical robotics, with a focus on enhancing robotic productivity and efficiency.

Major companies in the medical robotics market are focusing on innovative products, particularly robotic platforms, to better serve their existing consumers. A robotic solution refers to a comprehensive application or solution that utilizes robotic technology to address specific tasks, issues, or demands. For example, in May 2023, Robocath, a France-based company specializing in medical robotic solutions for heart-related diseases, introduced an innovative robotic platform called the R-One+. The R-One+ robotic system enables interventional cardiologists to perform coronary angioplasties by controlling the devices using a centralized command unit in the cathlab or control room. This approach offers two key advantages: it protects the cardiologist and medical staff from radiation-related risks, and it streamlines and secures the PCI (Percutaneous Coronary Intervention) process. Cardiologists can now perform more precise hand movements in more ergonomic working environments, ultimately benefiting patients. This focus on advanced robotic platforms reflects the industry's commitment to enhancing medical procedures and outcomes through robotic technology.

In April 2023, CardioVentures Inc., a UK-based medical device company, merged with AVRA Medical Robotics Inc. for an undisclosed sum. Following the merger, AVRA Medical Robotics aims to allocate a significant portion of its resources to expanding and reinforcing the operations of SSI-India, which will become the company's indirect majority-owned subsidiary. As part of this transition, the company's name has been changed to SS Innovations International, Inc. AVRA Medical Robotics Inc. is known for developing medical robot software and artificial intelligence.

Major companies operating in the medical robotics market report are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, GE Healthcare, Philips Healthcare, Boston Scientific Corporation, Intuitive Surgical, Smith & Nephew plc, BD Rowa, KUKA Roboter GmbH, Varian Medical Systems, Kirby, Omnicell, Auris Health Inc., iRobot Corporation, Globus Medical, Hansen Medical, Renishaw plc, Accuray Inc., Kinova Robotics, Hocoma AG, Titan Medical Inc., Ekso Bionics, TransEnterix Inc., ReWalk Robotics, Mazor Robotics, Houston Medical Robotics, ARxIUM, Medrobotics Corporation

North America will be the largest region in the medical robotics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical robotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical robotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical robotics market consists of sales of surgical robots / robot-assisted surgery machine, rehabilitation robots, laboratory robots, hospital robots, social robots. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Robotics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical robotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical robotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical robotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Surgical Robotics Systems; Rehabilitation Robotics Systems; Non-invasive Radiosurgery Systems
• 2) By Application: Laparoscopy; Neurosurgery; Cardiology; Orthopedic Surgery; Pharmacy Applications
• 3) By End-User: Hospitals And Clinics; Specialty Centers; Rehabilitation Centers
• Companies Mentioned: Johnson & Johnson; Medtronic plc; Siemens Healthineers AG; Stryker Corporation; GE Healthcare
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.